检索结果 - Naidoo, Jarushka

PD-1 and PD-L1 inhibitor toxicities in non-small cell lung cancer 由 Shankar, Bairavi, Naidoo, Jarushka

获取全文 获取全文 获取全文

A Multidisciplinary Approach for Patients with Preexisting Lung Diseases and Immune Checkpoint Inhibitor Toxicities 由 Naidoo, Jarushka, Suresh, Karthik

获取全文 获取全文 获取全文

Immunotherapy for Stage III NSCLC: Durvalumab and Beyond 由 Fitzpatrick, Orla, Naidoo, Jarushka

获取全文 获取全文 获取全文

Immune-related adverse events and the balancing act of immunotherapy 由 Conroy, Michael, Naidoo, Jarushka

获取全文 获取全文 获取全文

Immune-Related Adverse Events: A Case-Based Approach 由 Connolly, Caoilfhionn, Bambhania, Kalindi, Naidoo, Jarushka

获取全文 获取全文 获取全文

4401 Incidence, management, and outcomes of immune-related adverse events (irAEs): an analysis of a multidisciplinary toxicity team for cancer immunotherapy related irAEs 由 Balaji, Aanika, Zhang, Jiajia, Naidoo, Jarushka

获取全文 获取全文

An adapted anti-CTLA4 therapeutic aimed at mitigating the toxicities of checkpoint inhibition 由 Naidoo, Jarushka, Dykema, Arbor, D’Alessio, Franco

获取全文 获取全文 获取全文

Successful Treatment of Scar Pain with Scrambler Therapy 由 Yarchoan, Mark, Naidoo, Jarushka, Smith, Thomas J

获取全文 获取全文 获取全文

Treatment of Complications from Immune Checkpoint Inhibition in Patients with Lung Cancer 由 Wills, Beatriz, Brahmer, Julie R., Naidoo, Jarushka

获取全文 获取全文 获取全文

What does the future hold for immunotherapy in cancer? 由 Naidoo, Jarushka, Li, Bob T., Schindler, Katja, Page, David B.

获取全文 获取全文 获取全文

The 2014 San Antonio Breast Cancer Symposium: A successful lift-off for breast immunotherapy? 由 Page, David B, Naidoo, Jarushka, McArthur, Heather L

获取全文 获取全文

Immune Checkpoint Immunotherapy for Non-Small Cell Lung Cancer: Benefits and Pulmonary Toxicities 由 Suresh, Karthik, Naidoo, Jarushka, Lin, Cheng Ting, Danoff, Sonye

获取全文 获取全文 获取全文

Immune-mediated ototoxicity associated with immune checkpoint inhibitors in patients with melanoma 由 Rosner, Samuel, Agrawal, Yuri, Sun, Daniel Q, Aygun, Nafi, Schollenberger, Megan D, Lipson, Evan, Naidoo, Jarushka

获取全文 获取全文 获取全文

Cutaneous adverse events of immune checkpoint inhibitor therapy: incidence and types of reactive dermatoses 由 Le, Thomas K., Kaul, Subuhi, Cappelli, Laura C., Naidoo, Jarushka, Semenov, Yevgeniy R., Kwatra, Shawn G.

获取全文 获取全文 获取全文

Patterns of long-term survival following Ipilimumab (Ipi): the Memorial Sloan Kettering Cancer Center 10-year metastatic melanoma (MM) experience 由 Page, David B, Naidoo, Jarushka, Momtaz, Parisa, Bogatch, Kita, Kuk, Deborah, Panageas, Katherine, Yuan, Jianda, Wolchok, Jedd D, Postow, Michael

获取全文 获取全文

2568 Pembrolizumab for patients with leptomeningeal disease from advanced solid tumors 由 Naidoo, Jarushka, Hu, Chen, Schrek, Karisa, Connolly, Roisin, Santa-Maria, Cesar, Lipson, Evan, Mehra, Ranee, Bettegowda, Redmond, Kristin, Venkatesan, Arun, Grossman, Stuart

获取全文 获取全文

The cost of cancer care: how far would you go for a trial? 由 Fitzpatrick, Orla M., Murphy, Catherine, Duignan, Erica, Egan, Keith, Hennessy, Bryan T., Grogan, Liam, Murphy, Adrian, Breathnach, Oscar S., Naidoo, Jarushka, Morris, Patrick G.

获取全文 获取全文 获取全文

Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen 由 Cappelli, Laura C., Brahmer, Julie R., Forde, Patrick M., Le, Dung T., Lipson, Evan J., Naidoo, Jarushka, Zheng, Lei, Bingham, Clifton O., Shah, Ami A.

获取全文 获取全文 获取全文

Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies 由 Chen, Xuguang, Sheikh, Khadija, Nakajima, Erica, Lin, Cheng Ting, Lee, Junghoon, Hu, Chen, Hales, Russell K., Forde, Patrick M., Naidoo, Jarushka, Voong, Khinh Ranh

获取全文 获取全文 获取全文

Adaptive neoadjuvant chemotherapy guided by (18)F-FDG-PET in resectable non-small-cell lung cancers: the NEOSCAN trial 由 Chaft, Jamie E., Dunphy, Mark, Naidoo, Jarushka, Travis, William D., Hellmann, Matthew, Woo, Kaitlin, Downey, Robert, Rusch, Valerie, Ginsberg, Michelle S., Azzoli, Christopher G., Kris, Mark G.

获取全文 获取全文 获取全文